Skip to main content
HairCited

엽산 관련 휴지기 탈모

B

총 4,166명의 참여자를 대상으로 한 6건의 연구에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

There is limited evidence connecting folate to telogen effluvium — while low folate levels have been observed in some patients, research does not yet support folate supplementation as a reliable approach for this condition.

  • Mixed results across 6 studies — no consistent pattern linking folate levels to telogen effluvium
  • All studies are observational; no randomized controlled trials exist for this specific use
  • Folate is one of many micronutrients that may play a supporting role in hair health
  • A comprehensive nutritional assessment may be more useful than supplementing folate alone

Key Study Findings

Retrospective cohort n=2851
Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single-Center Experience.
Dose: None vs: Placebo 효과: Ferritin low in 46.5% of patients; iron deficiency in 29.5% p<0.05
retrospective cohort study n=3028
Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients …
Dose: standard replacement doses vs: Placebo 효과: vitamin D deficient: 72.2%; B12 deficient: 30.7%; iron deficiency anemia: 6.2% None
randomized controlled trial 26 weeks
Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium.
Dose: recommended daily intake amounts; taken orally for 180 days vs: Placebo 효과: Group 1 trichoscopy improvement 11.09% vs Group 2 7.76% after 180 days (significant for Group 1 only P<0.05 for clinical parameters

Key Statistics

10

연구

7126

참여자

Mixed

B

등급

Referenced Papers

Acta dermatovenerologica Croatica … 2016 6 인용
Dermatologic clinics 1993 38 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
400 mcg DFE/day

상한량: 1,000 mcg/day (synthetic folic acid)

연구에서 사용된 용량

용량 기간 효과 N
None -- Neutral 2851
None -- Mixed --
None -- Mixed 108
None -- Positive 973
standard replacement doses -- Neutral 3028
recommended daily intake amounts; taken orally for 180 days 26 weeks Positive --
psychiatric and dermatological management -- Neutral 1
None -- Negative --

권장 복용 시간: With meals for better absorption

Safety & Side Effects

보고된 부작용

  • Generally well tolerated
  • May mask vitamin B12 deficiency symptoms at high doses
  • Rare: abdominal cramps, insomnia

알려진 상호작용

  • Methotrexate (folate antagonist; consult physician)
  • Anticonvulsants (phenytoin, carbamazepine) may reduce folate levels
  • Sulfasalazine (reduces folate absorption)

일일 최대 섭취 허용량: 1,000 mcg/day (synthetic folic acid)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 엽산 help with 휴지기 탈모?
Based on 10 studies with 7,126 participants, there is moderate evidence from clinical studies that 엽산 may support 휴지기 탈모 management. Our evidence grade is B (Good Evidence).
How much 엽산 should I take for 휴지기 탈모?
Studies have used various dosages. A commonly studied range is 400 mcg DFE/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 엽산?
Reported side effects may include Generally well tolerated, May mask vitamin B12 deficiency symptoms at high doses, Rare: abdominal cramps, insomnia. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 엽산 and 휴지기 탈모?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 7,126 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.